Prognosis of aphasia in stroke patients early after iv thrombolysis

Clin Neurol Neurosurg. 2013 Mar;115(3):289-92. doi: 10.1016/j.clineuro.2012.05.019. Epub 2012 Jun 26.

Abstract

Objective: Stroke patients with aphasia have a high long-term morbidity. Intravenous rt-PA (iv) thrombolysis is given more deliberately to these patients. Early outcome data is lacking. Aim of this study was to determine early benefit from rt-PA in patients with aphasia.

Methods: Data of stroke patients treated by iv thrombolysis was scrutinized for the presence of aphasia defined as ≥1 point for aphasia on the National Institute of Health Stroke Scale (NIHSS). Improvement was defined as a gain of ≥1 point within 24h. Cranial computed tomography (CT) scans were evaluated regarding early ischemic changes (EICs), infarct volume and localization.

Results: Fifty patients with aphasia were included. 16 (32%) of patients improved (4 (36%) minor, 7 (41%) moderate, 5 (23%) major stroke patients), while 44 (62%) remained unchanged. Of 28 patients with EICs, 10 (36%) improved compared to 7 out of 22 (32%) patients without (p=0.773). Aphasia outcome was significantly associated with infarct volume at admission and at 24h (Kruskal-Wallis, p=0.033, p≤0.001, respectively).

Conclusion: EICs are not predictive of aphasia outcome and patients with improvement showed smaller infarct volumes. One third improved within 24h, while two thirds remained unchanged. This might justify a closer follow-up of aphasia in stroke patients at the acute stage.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Aphasia / etiology*
  • Aphasia / rehabilitation
  • Brain / pathology
  • Brain Ischemia / pathology
  • Cerebral Infarction / pathology
  • Echocardiography, Transesophageal
  • Female
  • Fibrinolytic Agents / administration & dosage
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Injections, Intravenous
  • Male
  • Middle Aged
  • Neurologic Examination
  • Neuropsychological Tests
  • Prognosis
  • Risk Factors
  • Sex Factors
  • Stroke / complications*
  • Stroke / drug therapy*
  • Stroke Rehabilitation
  • Thrombolytic Therapy*
  • Tissue Plasminogen Activator / administration & dosage
  • Tissue Plasminogen Activator / therapeutic use*
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator